Publications by authors named "Bockmann J"

Article Synopsis
  • Bulevirtide (BLV) is a new treatment approved in Europe for hepatitis D virus (HDV) infections, and this study examines its effectiveness using paired liver biopsies taken before and after treatment.
  • The results showed significant reductions in intrahepatic HDV RNA levels after 24 and 48 weeks of BLV treatment, alongside decreases in liver inflammation markers.
  • The study suggests that by blocking virus entry, BLV may reduce liver damage and potentially lead to a cure for some patients with long-term use.
View Article and Find Full Text PDF

The Shank3 gene encodes the major postsynaptic scaffolding protein SHANK3. Its mutation causes a syndromic form of autism spectrum disorder (ASD): Phelan-McDermid Syndrome (PMDS). It is characterized by global developmental delay, intellectual disorders (ID), ASD behavior, affective symptoms, as well as extra-cerebral symptoms.

View Article and Find Full Text PDF

Phelan-McDermid syndrome (PMS) is a syndromic form of Autism Spectrum Disorders (ASD) classified as a rare genetic neurodevelopmental disorder featuring global developmental delay, absent or delayed speech, ASD-like behaviour and neonatal skeletal muscle hypotonia. PMS is caused by a heterozygous deletion of the distal end of chromosome 22q13.3 or mutations.

View Article and Find Full Text PDF
Article Synopsis
  • Hepatitis D virus (HDV) is linked to severe viral hepatitis and this study investigates antibody levels in 40 chronic hepatitis D (CHD) patients compared to 70 chronic hepatitis B (CHB) patients.
  • The study found that CHD patients have significantly higher non-disease-specific antibody (NOSA) titers and immunoglobulin G (IgG) levels than CHB patients, with CHD showing 69% and 16.9 g/L respectively.
  • Autoantibodies in CHD patients are common but have unclear clinical implications, and their IgG levels correlate with higher viral loads and liver damage indicators, regardless of prior treatment with pegylated interferon-α.
View Article and Find Full Text PDF

Background & Aims: Pegylated interferon alpha (pegIFNα) is commonly used for the treatment of people infected with HDV. However, its mode of action in HDV-infected cells remains elusive and only a minority of people respond to pegIFNα therapy. Herein, we aimed to assess the responsiveness of three different cloned HDV strains to pegIFNα We used a previously cloned HDV genotype 1 strain (dubbed HDV-1a) that appeared insensitive to interferon-α , a new HDV strain (HDV-1p) we isolated from an individual achieving later sustained response to IFNα therapy, and one phylogenetically distant genotype 3 strain (HDV-3).

View Article and Find Full Text PDF

Mutations of the postsynaptic scaffold protein Shank2 lead to autism spectrum disorders (ASD). These patients frequently suffer from higher fracture risk. Here, we investigated whether Shank2 directly regulates bone mass.

View Article and Find Full Text PDF

Individuals with a -related neurodevelopmental disorder, also termed Phelan-McDermid syndrome or abbreviated as PMS, exhibit significant global developmental delay, language impairment, and muscular hypotonia. Also common are repetitive behaviors and altered social interactions, in line with a diagnosis of autism spectrum disorders. This study investigated the developmental aspect of autism-related behaviors and other phenotypes in a -transgenic mouse model.

View Article and Find Full Text PDF

Background: Autism spectrum disorder (ASD) is mainly characterized by deficits in social interaction and communication and repetitive behaviors. Known causes of ASD are mutations of certain risk genes like the postsynaptic protein SHANK3 and environmental factors including prenatal infections.

Methods: To analyze the gene-environment interplay in ASD, we combined the Shank3Δ11-/- ASD mouse model with maternal immune activation (MIA) via an intraperitoneal injection of polyinosinic/polycytidylic acid (Poly I:C) on gestational day 12.

View Article and Find Full Text PDF

Members of the Shank protein family are master scaffolds of the postsynaptic architecture and mutations within the SHANK genes are causally associated with autism spectrum disorders (ASDs). We generated a Shank2-Shank3 double knockout mouse that is showing severe autism related core symptoms, as well as a broad spectrum of comorbidities. We exploited this animal model to identify cortical brain areas linked to specific autistic traits by locally deleting Shank2 and Shank3 simultaneously.

View Article and Find Full Text PDF

Mutations or deletions of the SHANK3 gene are causative for Phelan-McDermid syndrome (PMDS), a syndromic form of autism spectrum disorders (ASDs). We analyzed Shank3Δ11(-/-) mice and organoids from PMDS individuals to study effects on myelin. SHANK3 was found to be expressed in oligodendrocytes and Schwann cells, and MRI analysis of Shank3Δ11(-/-) mice revealed a reduced volume of the corpus callosum as seen in PMDS patients.

View Article and Find Full Text PDF

Autism spectrum disorders (ASDs) are characterized by repetitive behaviors and impairments of sociability and communication. About 1% of ASD cases are caused by mutations of , a major scaffolding protein of the postsynaptic density. We studied the role of SHANK3 in plastic changes of excitatory synapses within the central nervous system by employing mild traumatic brain injury (mTBI) in WT and knockout mice.

View Article and Find Full Text PDF

The COVID-19 pandemic has caused a rise in stress, mental health concerns, and externalizing behaviors in children and their caregivers across the globe and illuminated the need to reduce stress levels and support self-regulation skills in even the youngest of children. The goal of this literature review is to describe what research has shown about the use of mindfulness-based interventions (MBIs) to support young children's self-regulation in early childhood settings. A total of 18 research studies conducted between 2010 and 2021 were identified.

View Article and Find Full Text PDF
Article Synopsis
  • A new quantitative reverse transcription real-time PCR (RT-qPCR) assay for hepatitis delta virus (HDV) was developed using the fully automated cobas6800 platform to reduce variability in test results.
  • The assay achieved a lower limit of detection of 3.86 IU/ml and demonstrated strong linearity across different HDV genotypes, with no false positives recorded.
  • Clinical testing on 110 serum samples showed a high agreement rate of 97.3% with existing assays, highlighting the new method's reliability and effectiveness in molecular diagnostics.
View Article and Find Full Text PDF
Article Synopsis
  • Chronic hepatitis B virus (HBV) infections often lead to liver cancer (HCC) due to persistent virus and weak immune response, necessitating new treatments to restore antiviral immunity.
  • Researchers developed bispecific T-cell engager antibodies that activate T-cells against HBV-infected liver cells by targeting HBV envelope proteins, boosting both direct killing and cytokine-mediated control of the virus.
  • In mouse models, these antibodies successfully directed T-cell responses towards HBV-infected tumors, reducing tumor size and demonstrating potential as a new treatment for chronic hepatitis B and related liver cancer.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the impact of metabolic and cardiovascular diseases on liver disease progression in chronic hepatitis B (CHB) patients, revealing a significant rise in liver cirrhosis and related events in those with these comorbidities.
  • A retrospective analysis of 602 CHB patients showed that those with diabetes, obesity, hypertension, or coronary heart disease had higher rates of cirrhosis and liver-related incidents during a median follow-up of 2.51 years.
  • The findings highlight that hepatitis B patients with metabolic disorders, particularly diabetes, require closer monitoring and tailored treatment strategies due to their increased risk of severe liver complications.
View Article and Find Full Text PDF
Article Synopsis
  • Impairments in social interactions and awareness are common in autism spectrum disorders (ASDs), but the causes are not well understood.
  • Shank2 is a key gene associated with ASDs and is found mainly in the parts of the brain that process excitatory signals.
  • Research shows that mice lacking Shank2 exhibit social bonding deficits, but enhancing activity in a specific brain area, the medial preoptic area (MPOA), can restore these social behaviors.
View Article and Find Full Text PDF
Article Synopsis
  • The ectonucleotidases CD39 and CD73 are crucial in regulating immune responses by controlling the balance of ATP and adenosine during inflammation, potentially impacting COVID-19 pathology.
  • A study found that COVID-19 patients had significantly lower CD73 expression in their cytotoxic lymphocytes (like CD8 T cells, NKT, and NK cells) compared to healthy individuals, with the decrease linked to higher serum ferritin levels.
  • CD8 T cells and NKT cells without CD73 exhibited greater cytotoxic functions, indicating the need for further research on CD39 and CD73 in various disease stages and their use as potential therapeutic targets.
View Article and Find Full Text PDF

Older patients with severe physical trauma are at high risk of developing neuropsychiatric syndromes with global impairment of cognition, attention, and consciousness. We employed a thoracic trauma (TxT) mouse model and thoroughly analyzed age-dependent spatial and temporal posttraumatic alterations in the central nervous system. Up to 5 days after trauma, we observed a transient 50% decrease in the number of excitatory synapses specifically in hippocampal pyramidal neurons accompanied by alterations in attention and motor activity and disruption of contextual memory consolidation.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic hepatitis delta virus (HDV) infection can lead to severe liver issues such as cirrhosis and hepatocellular carcinoma (HCC), prompting a study to understand disease severity and outcomes based on various clinical and treatment factors.
  • A cohort of 49 patients was analyzed over an average of 3 years, revealing that severe clinical events were prevalent, with high occurrences of HCC, death, and liver transplants, primarily in those with existing liver cirrhosis.
  • The study identified low platelet count and older age as significant predictors of adverse clinical events, while treatment type (interferon vs nucleos(t)ide analogues) influenced HCC occurrence, emphasizing that advanced liver disease has a major impact on disease prognosis
View Article and Find Full Text PDF

Fetal pain has long been a contentious issue, in large part because fetal pain is often cited as a reason to restrict access to termination of pregnancy or abortion. We have divergent views regarding the morality of abortion, but have come together to address the evidence for fetal pain. Most reports on the possibility of fetal pain have focused on developmental neuroscience.

View Article and Find Full Text PDF

Objective: Heterozygous SHANK3 mutations or partial deletions of the long arm of chromosome 22, also known as Phelan-McDermid syndrome, result in a syndromic form of the autism spectrum as well as in global developmental delay, intellectual disability, and several neuropsychiatric comorbidities. The exact pathophysiological mechanisms underlying the disease are still far from being deciphered but studies of SHANK3 models have contributed to the understanding of how the loss of the synaptic protein SHANK3 affects neuronal function.

Methods And Results: Diffusion tensor imaging-based and automatic volumetric brain mapping were performed in 12 SHANK3-deficient participants (mean age 19 ± 15 years) versus 14 age- and gender-matched controls (mean age 29 ± 5 years).

View Article and Find Full Text PDF
Article Synopsis
  • * It finds minor variations in α4β7 expression on CD4+ T cells across different health statuses and treatment with vedolizumab (VDZ), an anti-α4β7 therapy, in peripheral blood and tissues.
  • * Results indicate that HIV-infected individuals have fewer α4β7+ CD4+ effector memory T cells, which do not recover even with antiretroviral treatment, while VDZ treatment leads to a decrease in naïve α4β7+ T cells, highlighting the need
View Article and Find Full Text PDF

Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders characterized by deficits in social interaction and communication, and repetitive behaviors. In addition, co-morbidities such as gastro-intestinal problems have frequently been reported. Mutations and deletion of proteins of the SH3 and multiple ankyrin repeat domains () gene-family were identified in patients with ASD, and knock-out mouse models display autism-like phenotypes.

View Article and Find Full Text PDF
Article Synopsis
  • Type III interferons (IFNs) - specifically IFN-β and IFN-λ - were assessed for their ability to reduce hepatitis B virus (HBV) DNA in infected liver cells, similar to type I interferons (IFN-α).
  • Experiments showed that both IFN-β and IFN-λ effectively lowered levels of HBV DNA, demonstrating comparable efficiency to IFN-α in inducing changes in the viral genome.
  • The findings suggest that IFN-β and IFN-λ have the potential to be developed into new treatments for HBV by promoting the degradation of cccDNA, a key target in HBV therapy.
View Article and Find Full Text PDF

Research efforts over the past decades have unraveled both genetic and environmental factors, which contribute to the development of autism spectrum disorders (ASD). It is, to date, largely unknown how different underlying causes result in a common phenotype. However, the individual course of development and the different comorbidities might reflect the heterogeneous genetic and non-genetic contributions.

View Article and Find Full Text PDF